Editas Medicine Inc.

NASDAQ: EDIT · Real-Time Price · USD
3.04
0.08 (2.70%)
At close: Aug 15, 2025, 3:59 PM
2.97
-2.30%
After-hours: Aug 15, 2025, 05:09 PM EDT

Editas Medicine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.58M 4.66M 30.6M 61K 513K 1.14M 60.05M 5.34M 2.89M 9.85M 6.54M 42K 6.36M 6.77M 12.47M 6.2M 379K 6.5M
Cost of Revenue
n/a 907K 1.38M 1.6M 1.42M 1.41M 1.47M 1.51M 1.54M 1.54M 1.58M 1.6M 1.6M 1.56M 1.51M 29.27M 33.75M 41.94M
Gross Profit
3.58M 4.66M 29.22M -1.54M -907K -274K 58.58M 3.82M 1.35M 8.31M 4.96M -1.56M 4.76M 5.21M 10.96M -23.07M -33.37M -35.44M
Operating Income
-51.54M -76.16M -46.59M -65.67M -71.9M -66.99M -23.96M -50.16M -44.09M -50.96M -63.45M -57.52M -54.23M -50.75M -41.61M -39.25M -55.4M -56.88M
Interest Income
2.09M 2.72M 1.2M 3.53M 4.3M 5.04M 5.1M 5.14M 3.81M 3.51M 1.42M 1.79M 546K 469K 1.91M 152K 146K 134K
Pretax Income
-53.23M -76.09M -45.4M -62.14M -67.61M -61.95M -18.87M -45.02M -40.29M -49.04M -60.74M -55.73M -53.45M -50.52M -41.44M -39.08M -55.26M -56.73M
Net Income
-53.23M -76.09M -45.4M -62.14M -67.61M -61.95M -18.87M -45.02M -40.29M -45.57M -55.03M -53.93M -52.67M -50.28M -41.44M -39.08M -55.26M -56.73M
Selling & General & Admin
12.86M 13.38M 16.35M 18.09M 18.21M 19.34M 14.46M 14.99M 17.2M 23.01M 17.98M 16.24M 16.94M 19.55M 16.53M 16.18M 22.03M 21.45M
Research & Development
16.18M 26.59M 48.61M 47.64M 52.79M 47.38M 68.09M 5.34M 29.78M 37.8M 52M 41.33M 43.66M 37.98M 37.55M 29.27M 33.75M 41.94M
Other Expenses
26.08M 40.85M -36.38M -1.6M n/a n/a n/a 33.66M -7K -1.58M 1.29M 1K 235K -234K -325K 19K -509K 21K
Operating Expenses
55.12M 80.82M 28.59M 64.13M 71M 66.72M 82.55M 53.98M 46.98M 60.81M 69.98M 57.56M 60.6M 57.52M 54.08M 45.45M 55.78M 63.38M
Interest Expense
2.02M 2.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
55.12M 80.82M 77.2M 65.73M 72.42M 68.13M 84.01M 55.5M 46.98M 60.81M 69.98M 57.56M 60.6M 57.52M 54.08M 45.45M 55.78M 63.38M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.47M -5.7M -1.79M -781K -235K n/a -152K n/a n/a
Shares Outstanding (Basic)
84.41M 83.06M 82.61M 82.49M 82.31M 81.94M 81.71M 81.65M 71.38M 68.92M 68.79M 68.74M 68.64M 68.26M 68.36M 68.22M 67.88M 65.99M
Shares Outstanding (Diluted)
84.41M 83.06M 82.61M 82.49M 82.31M 81.94M 81.71M 81.65M 71.38M 68.92M 68.79M 68.74M 68.64M 68.48M 68.36M 68.22M 67.88M 65.99M
EPS (Basic)
-0.63 -0.92 -0.55 -0.75 -0.82 -0.76 -0.23 -0.55 -0.56 -0.66 -0.8 -0.78 -0.77 -0.74 -0.61 -0.57 -0.81 -0.86
EPS (Diluted)
-0.63 -0.92 -0.55 -0.75 -0.82 -0.76 -0.23 -0.55 -0.56 -0.66 -0.8 -0.78 -0.77 -0.73 -0.61 -0.57 -0.81 -0.86
EBITDA
-49.38M -71.95M -44.01M -60.54M -70.48M -65.58M -22.5M -48.65M -42.55M -49.42M -61.87M -55.92M -52.64M -49.19M -40.1M -38.06M -54.21M -55.72M
EBIT
-51.22M -73.87M -45.4M -62.14M -71.9M -66.99M -23.96M -50.16M -44.09M -50.96M -63.45M -57.52M -54.23M -50.75M -41.61M -39.25M -55.4M -56.88M
Depreciation & Amortization
1.83M 1.92M 1.38M 1.6M 1.42M 1.41M 1.47M 1.51M 1.54M 1.54M 1.58M 1.6M 1.6M 1.56M 1.51M 1.19M 1.19M 1.16M